from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0483/lprQ

LFCtreatmentdescriptionclass of inhibitor

-0.762

Amikacinug/mL Amikacintranslation

-0.238

Cap5-10ug/mL Capreomycintranslation

0.226

Rox10-50 ug/mL Roxithromycintranslation

0.925

SM2-5 ug/mL Streptomycintranslation

-0.761

Tet5-10 ug/mL Tetracyclinetranslation

-2.047

Rif0.2-5ug/mL Rifampicintranscription

-0.339

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.626

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.881

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.286

CPZ10-50 ug/mL Chlorpromazinerespiration

0.025

Clofazimine10-13 ug/mL Clofaziminerespiration

0.671

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.186

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.431

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.082

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.693

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.352

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.231

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.706

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.087

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.636

KCN5-20 ug/mL Potassium cyaniderespiration

0.918

NaN30.2-2 mM Sodium aziderespiration

1.281

Nigericin50 uM Nigericinrespiration

-1.182

TRC10-150 ug/mL Triclosanrespiration

-0.998

TRZ10-25 ug/mL Thioridazinerespiration

-0.354

Valinomycin0.5-10 uM Valinomycinrespiration

0.565

ZnSO42 mM ZnSO4respiration

1.017

menadione6-10 ug/mL Menadionerespiration

0.897

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.284

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.639

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.154

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.496

NRP_1Non-replicating persistence stage 1dosRassociated

0.570

Amp0.2mg/mL AmpicillincellWall

0.018

Cephalexin20-100 ug/mL CephalexincellWall

1.203

Cerulenin0.32-5 ug/mL CerulenincellWall

0.086

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.420

EMB10-20 ug/mL EthambutolcellWall

0.885

Eta12-40 ug/mL EthionamidecellWall

1.157

INH0.2-0.4 ug/mL IsoniazidcellWall

0.645

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.056

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.124

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.956

BZA0.12 mg/mL BenzamidearomaticAmides

-0.855

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.701

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.134

H2O24 mM hydrogen peroxideDNAdamaging

-0.208

Levo10 ug/mL LevofloxacinDNAdamaging

0.720

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.311

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.304

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.771

UVUV-irradiationDNAdamaging

-0.664

ARP41-4 ug/mL Antitubercular compound ARP4?

0.621

Antimycin12.5-50 ug/mL Antimycin A?

-0.213

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.493

PA_110-50 ug/mL Antitubercular compound PA-1?

1.215

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.167

PA8240.2-2 ug/mL PA-824?

0.554

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.286

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.688

Verapamil50 uM Verapamil?

-0.308

mercaptoethanol2 mM 2-Mercaptoethanol?

0.616

methoxatin10-20 ug/mL Methoxatin?